Why Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks24/7 Wall Street • 07/30/20
Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/30/20
Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/30/20
Earnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to DeclineZacks Investment Research • 07/23/20
5 Greenblatt Magic Formula Biotech Stocks to Weather the Summer Coronavirus StormGuruFocus • 07/07/20
Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery CaseThe Motley Fool • 07/06/20
Alexion's European Approval And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 06/30/20
Alexion (ALXN) Up 17.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/20